Skip Navigation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Carroll, G. J.
Right arrow Articles by Ma, D. T.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Carroll, G. J.
Right arrow Articles by Ma, D. T.
Related Collections
Right arrow Spondylarthropathies
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology 2001; 40: 945-947
© 2001 British Society for Rheumatology

Letters to the Editor

Effective control of incomplete reactive arthritis with cyclosporin

G. J. Carroll and D. T. Ma

University Department of Medicine, Royal Perth Hospital, Department of Rheumatology, Level 1, Q Block, 6 Selby Street, Shenton Park, WA 6008, Australia

SIR, In some studies 10–20% of patients with Reiter's syndrome (RS) and reactive arthritis (ReA) were found to have persistent disease 2 yr after the onset of symptoms [1]. In these cases various agents were used to stem progression, including sulphasalazine (SAS), methotrexate (MTX) and azathioprine (AZA). Combination therapies with or without corticosteroids have also been tried [2].

Cyclosporin A (CyA) is an established disease-modifying agent in rheumatoid arthritis [3]. There have been case reports of successful treatment of RS and . . . [Full Text of this Article]

Notes

References


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?